Lipomics raises $2.8M for metabolic diagnostics
Lipomics, a West Sacramento, Calif., biotech, raised $2.8 million in a fourth funding round, VentureWire reports (subscription required). Among the investors was DFJ Frontier.
Lipomics is developing diagnostic tests for important measures of metabolic function that may be useful in managing and treating conditions such as diabetes, obesity, and heart disease.
Next Story: Venture firm throws money at Facebook leeches
Previous Story: Origin BioMed raises $3.8M for natural health products
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.